You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic myelogenous leukemia in chronic phase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 12, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

Not yet recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • APN and medical management
  • +3 more
  • Avignon, Provence-Alpes-Côte d'Azur, France
    Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Oct 13, 2023

Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Dasatinib Pill
  • Ketoconazole Pill
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. José Eleuterio González
Nov 25, 2022

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 24, 2022

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

    Recruiting
    • Chronic Myeloid Leukemia in Myeloid Blast Crisis
    • +3 more
    • based decitabine and olverembatinib（HQP1351)chemotherapy
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Dec 6, 2022

    Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Jena, Germany
        University Hospital Jena
      Jan 17, 2023

      Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

      Not yet recruiting
      • Leukemia
      • +12 more
      • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
      • (no location specified)
      Mar 20, 2023

      Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

      Active, not recruiting
      • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 2, 2022

      CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

      Recruiting
      • CML
      • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
      • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
        FUNDALEU
      Jun 29, 2023

      Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 11, 2022

      Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

      Recruiting
      • Chronic Myelogenous Leukemia
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 27, 2022

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
      • (no location specified)
      Jun 7, 2022

      Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

      Not yet recruiting
      • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
      • (no location specified)
      Jul 11, 2022

      Chronic Myeloid Leukemia Trial (Asciminib)

      Available
      • Chronic Myeloid Leukemia
      • (no location specified)
      Jan 17, 2023

      CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

      Recruiting
      • CML, Chronic Phase
      • CML, Accelerated Phase
      • HS-10382(Part 1: Dose escalation)
      • HS-10382(Part 2: Dose expansion)
      • Wuhan, Hubei, China
        Union Hospital affiliated to Tongji Medical College of Huazhong
      Jan 12, 2023

      Chronic Leukemia Trial in France (Additional biological samples)

      Active, not recruiting
      • Chronic Leukemia
      • Additional biological samples
      • Besançon, France
      • +3 more
      May 31, 2022

      Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

      Recruiting
      • Acute Biphenotypic Leukemia
      • +13 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023

      CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

      Not yet recruiting
      • CML (Chronic Myelogenous Leukemia
      • (no location specified)
      Jul 27, 2022

      Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

      Recruiting
      • Myeloproliferative Neoplasm
      • +2 more
      • Online Mindfulness Meditation
      • Internet-Based Webinars
      • San Francisco, California
        University of California San Francisco
      Aug 9, 2022

      Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

      Recruiting
      • Chronic Myelogenous Leukemia - Chronic Phase
      • Birmingham, Alabama
      • +25 more
      Jan 10, 2023

      Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • +3 more
      • Augusta, Georgia
      • +1 more
      Jul 14, 2022